Eindhoven, Netherlands

Anton Egbert Adang

This inventor holds 3 USPTO granted patents. Top assignee: Akzo Nobel N.v.. Active years: 1999-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anton Egbert Adang. Retrieved from https://idiyas.com/inventor/anton-egbert-adang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1999-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Anton Egbert Adang: Innovator in Serine Protease Inhibitors

Introduction

Anton Egbert Adang is a notable inventor based in Eindhoven, Netherlands. He has made significant contributions to the field of biochemistry, particularly in the development of serine protease inhibitors. With a total of 3 patents to his name, Adang's work has implications in various therapeutic areas.

Latest Patents

Among his latest patents, Adang has focused on the creation of imidazo[1,5-a]pyridine derived serine protease inhibitors. These innovations are crucial in advancing the understanding and treatment of diseases related to protease activity.

Career Highlights

Adang is currently associated with Akzo Nobel N.V., a leading global paints and coatings company. His role at Akzo Nobel allows him to leverage his expertise in biochemistry to contribute to innovative solutions in the industry.

Collaborations

Throughout his career, Adang has collaborated with esteemed colleagues such as Adrianus Petrus De Man and Jacobus Albertus Peters. These partnerships have fostered a collaborative environment that enhances the research and development of new technologies.

Conclusion

Anton Egbert Adang's contributions to the field of serine protease inhibitors highlight his innovative spirit and dedication to scientific advancement. His work continues to influence the landscape of biochemistry and therapeutic development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…